These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

661 related items for PubMed ID: 15380140

  • 1. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.
    Hart R, Hickey M, Franks S.
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):671-83. PubMed ID: 15380140
    [Abstract] [Full Text] [Related]

  • 2. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 3. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
    Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC.
    BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
    [Abstract] [Full Text] [Related]

  • 4. [The role of leptin in polycystic ovary syndrome].
    Marciniak A, Starczewski A.
    Pol Merkur Lekarski; 2008 Oct; 25(148):390-3. PubMed ID: 19145943
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic criteria in polycystic ovary syndrome.
    Legro RS.
    Semin Reprod Med; 2003 Aug; 21(3):267-75. PubMed ID: 14593549
    [Abstract] [Full Text] [Related]

  • 6. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population.
    Pehlivanov B, Orbetzova M.
    Gynecol Endocrinol; 2007 Oct; 23(10):604-9. PubMed ID: 17852429
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.
    Carmina E, Azziz R.
    Fertil Steril; 2006 Jul; 86 Suppl 1():S7-8. PubMed ID: 16798288
    [Abstract] [Full Text] [Related]

  • 8. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.
    March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ.
    Hum Reprod; 2010 Feb; 25(2):544-51. PubMed ID: 19910321
    [Abstract] [Full Text] [Related]

  • 9. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.
    Kumarapeli V, Seneviratne Rde A, Wijeyaratne CN, Yapa RM, Dodampahala SH.
    Am J Epidemiol; 2008 Aug 01; 168(3):321-8. PubMed ID: 18550559
    [Abstract] [Full Text] [Related]

  • 10. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC, Galluzzo A, Finocchiaro S, Criscimanna A, Giordano C.
    Clin Endocrinol (Oxf); 2008 Jul 01; 69(1):52-60. PubMed ID: 18034780
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome.
    Lowenstein EJ.
    Dermatol Ther; 2006 Jul 01; 19(4):210-23. PubMed ID: 17004997
    [Abstract] [Full Text] [Related]

  • 12. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF, Li X, Zhu MW.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct 01; 41(10):684-8. PubMed ID: 17199924
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of polycystic ovarian syndrome in Indian adolescents.
    Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R.
    J Pediatr Adolesc Gynecol; 2011 Aug 01; 24(4):223-7. PubMed ID: 21600812
    [Abstract] [Full Text] [Related]

  • 14. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria.
    Franks S.
    J Clin Endocrinol Metab; 2006 Mar 01; 91(3):786-9. PubMed ID: 16418209
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome.
    Goodarzi MO, Azziz R.
    Best Pract Res Clin Endocrinol Metab; 2006 Jun 01; 20(2):193-205. PubMed ID: 16772151
    [Abstract] [Full Text] [Related]

  • 16. [Polycystic ovary syndrome].
    Dewailly D.
    J Gynecol Obstet Biol Reprod (Paris); 2000 May 01; 29(3):298-301. PubMed ID: 10804375
    [Abstract] [Full Text] [Related]

  • 17. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
    Kurzrock R, Cohen PR.
    Med Hypotheses; 2007 May 01; 68(3):480-3. PubMed ID: 17134841
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.
    Alvarez-Blasco F, Botella-Carretero JI, San Millán JL, Escobar-Morreale HF.
    Arch Intern Med; 2006 Oct 23; 166(19):2081-6. PubMed ID: 17060537
    [Abstract] [Full Text] [Related]

  • 19. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria.
    Kauffman RP, Baker TE, Baker VM, DiMarino P, Castracane VD.
    Am J Obstet Gynecol; 2008 Jun 23; 198(6):670.e1-7; discussion 670.e7-10. PubMed ID: 18355776
    [Abstract] [Full Text] [Related]

  • 20. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria.
    Mueller A, Dittrich R, Binder H, Hoffmann I, Beckmann MW, Cupisti S.
    Eur J Med Res; 2006 Dec 14; 11(12):540-4. PubMed ID: 17182367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.